Tag: Prescription Drugs
Breyanzi Approved for Certain Types of Large B-Cell Lymphoma
The CAR T cell therapy OK'd for patients who have not responded to or have relapsed after receiving two or more other systemic treatments
Bimekizumab Superior to Ustekinumab for Plaque Psoriasis
More patients met targets for improvement in Psoriasis Area and Severity Index, Investigator's Global Assessment response at week 16
Small Study Tests Colchicine for Moderate-to-Severe COVID-19
Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19
Opioid-Minimizing Pain Management Feasible for Trauma Patients
MAST MMPR regimen includes oral acetaminophen, naproxen, gabapentin, lidocaine patches, and as-needed opioids
Rifaximin Prevents Overt Hepatic Encephalopathy After TIPS
For patients with cirrhosis, rifaximin reduces odds of overt HE after transjugular intrahepatic portosystemic shunt
U.S. Drug Prices 256 Percent Higher Than in 32 OECD Countries
U.S. prices higher than those in comparison countries for brand-name originator drugs, but lower for unbranded generics
Metformin Use for T2DM May Reduce COVID-19 Mortality
Odds of contracting COVID-19, COVID-19-related mortality higher for individuals with diabetes
Adverse Drug Reactions Linked to Hydroxychloroquine Up in 2020
ADRs associated with hydroxychloroquine, chloroquine more than doubled in 2020 versus 2018 and 2019
COVID-19 Outcomes No Worse for Patients on Immunosuppressive Meds
Findings for ventilator use, length of stay, in-hospital mortality similar for those with, without chronic use of immunosuppressant agents
No Evidence Found to Support Discontinuing ACEIs, ARBs in COVID-19
Mean number of days alive and out of hospital not significantly different for those discontinuing, continuing meds
